GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » JW Pharmaceutical (XKRX:001060) » Definitions » Float Percentage Of Total Shares Outstanding

JW Pharmaceutical (XKRX:001060) Float Percentage Of Total Shares Outstanding : 0.00% (As of Jun. 05, 2024)


View and export this data going back to 1976. Start your Free Trial

What is JW Pharmaceutical Float Percentage Of Total Shares Outstanding?

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, JW Pharmaceutical's float shares is 0.00 Mil. JW Pharmaceutical's total shares outstanding is 23.20 Mil. JW Pharmaceutical's float percentage of total shares outstanding is 0.00%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, JW Pharmaceutical's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, JW Pharmaceutical's Institutional Ownership is 8.11%.

JW Pharmaceutical Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

JW Pharmaceutical's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=0.00/23.20
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

JW Pharmaceutical (XKRX:001060) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » JW Pharmaceutical (XKRX:001060) » Definitions » Float Percentage Of Total Shares Outstanding
Comparable Companies
XKRX:003850 XKRX:019170 XKRX:000640 XKRX:003090 XKRX:086450 XKRX:243070 XKRX:170900 XKRX:249420 XKRX:003000 XKRX:003520 ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
001067:Korea 001065.PFD:Korea
Address
2477, Nambusunhwan-ro, Seocho-gu, KOR
Website
https://www.jw-pharma.co.kr
JW Pharmaceutical is active in the healthcare sector. It has been one of the leading companies in the pharmaceutical market on a global basis. Its original medicine and medical supply pipeline include Livalo, Thrupas, Sigmart and Actemra. It also develops low-protein and low-salt diet food for patients suffering from chronic renal insufficiency as well as general Pharmaceuticals and health care products.

JW Pharmaceutical (XKRX:001060) Headlines

No Headlines